The effect of PPAR isoform (de)activation on the lipid composition in Full Thickness Skin Models.

Human Skin Equivalents (HSEs) are 3D-cultured human skin models that mimic many aspects of native human skin (NHS). Although HSEs resemble NHS very closely, the barrier located in the stratum corneum (SC) is impaired. This is caused by an altered lipid composition in the SC of HSEs compared to NHS. One of the most pronounced changes in this lipid composition is a high level of monounsaturation. One key-enzyme in this change is Stearoyl-CoA Desaturase-1 (SCD1), which catalyzes the monounsaturation of lipids. In order to normalize the lipid composition, we aimed to target a group of nuclear receptors that are important regulators in the lipid synthesis. This group of receptors are known as the Peroxisome Proliferating Activating Receptors (PPARs). By (de)activating each isoform (PPAR-α, PPAR-δ, and PPAR-γ) the PPAR isoforms may have normalizing effects on the lipid composition. In addition, another PPAR-α agonist Wy14643 was included as this supplement demonstrated normalizing effects in the lipid composition in a more recent study. After PPAR (ant)agonists supplementation, the mRNA of downstream targets, lipid synthesis genes, and lipid composition were investigated. The PPAR downstream targets were activated, indicating that the supplements reached the keratinocytes to trigger their effect. However, minimal impact was observed on the lipid composition after PPAR isoforms (de)activation. Only the highest concentration Wy14643 resulted in strong, but negative effects on CER composition. Although the novel tested modifications did not result in an improvement, more insight is gained on the nuclear receptors PPARs and their effects on the lipid barrier in full thickness skin models.